Credit: Jae-Hyun Park D.V.M., Ph.D., Research Associate/Assistant Professor, Section of Hematology/Oncology, The University of Chicago
Illustration: OTS enters cancer cells where it inhibits TOPK, leading to inability to complete cell division, resulting in cell death.